A feasibility study of provider-level implementation strategies to improve access to colorectal cancer screening for patients with schizophrenia: ACCESS2 (N-EQUITY 2104) trial
- PMID: 38178209
- PMCID: PMC10768128
- DOI: 10.1186/s43058-023-00541-0
A feasibility study of provider-level implementation strategies to improve access to colorectal cancer screening for patients with schizophrenia: ACCESS2 (N-EQUITY 2104) trial
Abstract
Background: People with schizophrenia have a lower colorectal screening rate than the general population. A previous study reported an intervention using case management to encourage colorectal cancer screening for patients with schizophrenia in psychiatric outpatient settings. In this feasibility study, we developed provider-level implementation strategies and evaluated the feasibility of conducting a definitive trial in terms of the penetration of the intervention assessed at the patient level. Additionally, we examined the fidelity of strategies to implement the intervention at the provider level in a routine clinical psychiatric setting.
Methods: This was a multicenter, single-arm feasibility study with medical staff at psychiatric hospitals in Japan. The provider-level implementation strategies developed in this study included three key elements (organizing an implementation team appointed by the facility director, interactive assistance using a clear guide that outlines who in the hospital should do what, and developing accessible educational materials) to overcome major barriers to implementation of the intervention and four additional elements (progress monitoring, joint meetings and information sharing among participating sites, adaptation of encouragement methods to specific contexts, and education of on-site staff), with reference to the elements identified in the Expert Recommendations for Implementing Change (ERIC). The feasibility of the strategies was evaluated by the proportion of patients who were eligible for encouragement (patients with schizophrenia aged 40, 50, or 60) who received encouragement. We set the goal of providing encouragement to at least 40% of eligible patients at each site.
Results: Two public and four private psychiatric hospitals in Okayama and Shimane prefectures participated in this study. Regarding fidelity, all elements of the strategies were conducted as planned. Following the procedures in the guide, each team prepared and provided encouragement according to their own facility and region. Penetration, defined as the proportion of eligible patients who received encouragement, ranged from 33.3 to 100%; five of the six facilities achieved the target proportion.
Conclusions: The provider-level implementation strategies to implement encouragement were feasible in terms of penetration of the intervention assessed at the patient level. The results support the feasibility of proceeding with a future definitive trial of these strategies.
Trial registration: jRCT, jRCT1060220026 . Registered on 06/04/2022.
Keywords: Cancer screening; Case management; Implementation; Provider level; Schizophrenia.
© 2023. The Author(s).
Conflict of interest statement
M. F.1 has received honoraria for lectures from Mochida. Y. Y. has received honoraria for lectures from Meiji, Sumitomo Pharma, and Lundbeck. N. Y. has received grants from Eisai and Otsuka and has received honoraria for lectures from Eisai, Otsuka, Takeda, MSD, UCB, Viatris, Sumitomo Pharma, and Meiji. M. I. has received grants from Astellas, Eisai, Otsuka, Shionogi, Daiichi Sankyo, Sumitomo Pharma, Takeda, Mitsubishi Tanabe Pharma, Nihon Medi-Physics, Pfizer, Fujifilm, and Mochida and has received honoraria for lectures from EA Pharma, Meiji, MSD, Viatris, Eisai, Otsuka, Sumitomo Pharma, Takeda, Eli Lilly, Nippon Shinyaku, Pfizer, Mochida, Janssen, and Yoshitomiyakuhin. The other authors declare that they have no competing interests.
Similar articles
-
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z. Trials. 2021. PMID: 33419461 Free PMC article.
-
Patients' acceptability and implementation outcomes of a case management approach to encourage participation in colorectal cancer screening for people with schizophrenia: a qualitative secondary analysis of a mixed-method randomised clinical trial.BMJ Open. 2022 Jun 14;12(6):e060621. doi: 10.1136/bmjopen-2021-060621. BMJ Open. 2022. PMID: 35701062 Free PMC article. Clinical Trial.
-
A Pragmatic Clinical Trial of Hearing Screening in Primary Care Clinics: Effect of Setting and Provider Encouragement.Ear Hear. 2024 Jan-Feb 01;45(1):23-34. doi: 10.1097/AUD.0000000000001418. Epub 2023 Aug 21. Ear Hear. 2024. PMID: 37599396 Free PMC article. Clinical Trial.
-
Cue-based versus scheduled feeding for preterm infants transitioning from tube to oral feeding: the Cubs mixed-methods feasibility study.Health Technol Assess. 2021 Dec;25(74):1-146. doi: 10.3310/hta25740. Health Technol Assess. 2021. PMID: 34878383
-
Implementation strategies to support fall prevention interventions in long-term care facilities for older persons: a systematic review.BMC Geriatr. 2023 Jan 25;23(1):47. doi: 10.1186/s12877-023-03738-z. BMC Geriatr. 2023. PMID: 36698065 Free PMC article.
Cited by
-
Trends in uptake of cancer screening among people with severe mental illness before and after the COVID-19 pandemic in Japan: A repeated cross-sectional study.PCN Rep. 2025 Feb 2;4(1):e70062. doi: 10.1002/pcn5.70062. eCollection 2025 Mar. PCN Rep. 2025. PMID: 39902101 Free PMC article.
References
-
- World Health Organization . Cancer control: knowledge into action: WHO guide for effective programmes: module 3: early detection. Geneva: World Health Organization; 2007. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources